Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP789292.RAJJaL4ywclHiW9xpkLP0jmqMVUG_5HNy7s9HQaVFetYc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP789292.RAJJaL4ywclHiW9xpkLP0jmqMVUG_5HNy7s9HQaVFetYc130_assertion type Assertion NP789292.RAJJaL4ywclHiW9xpkLP0jmqMVUG_5HNy7s9HQaVFetYc130_head.
- NP789292.RAJJaL4ywclHiW9xpkLP0jmqMVUG_5HNy7s9HQaVFetYc130_assertion description "[Finally, RARA may be the key to unlocking the problem of resistance to all-trans retinoic acid (ATRA) in breast cancer sufferers; this treatment has previously been demonstrated to induce remission in over 80% of patients with acute promyelocytic leukaemia (APML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP789292.RAJJaL4ywclHiW9xpkLP0jmqMVUG_5HNy7s9HQaVFetYc130_provenance.
- NP789292.RAJJaL4ywclHiW9xpkLP0jmqMVUG_5HNy7s9HQaVFetYc130_assertion evidence source_evidence_literature NP789292.RAJJaL4ywclHiW9xpkLP0jmqMVUG_5HNy7s9HQaVFetYc130_provenance.
- NP789292.RAJJaL4ywclHiW9xpkLP0jmqMVUG_5HNy7s9HQaVFetYc130_assertion SIO_000772 20100636 NP789292.RAJJaL4ywclHiW9xpkLP0jmqMVUG_5HNy7s9HQaVFetYc130_provenance.
- NP789292.RAJJaL4ywclHiW9xpkLP0jmqMVUG_5HNy7s9HQaVFetYc130_assertion wasDerivedFrom befree-2016 NP789292.RAJJaL4ywclHiW9xpkLP0jmqMVUG_5HNy7s9HQaVFetYc130_provenance.
- NP789292.RAJJaL4ywclHiW9xpkLP0jmqMVUG_5HNy7s9HQaVFetYc130_assertion wasGeneratedBy ECO_0000203 NP789292.RAJJaL4ywclHiW9xpkLP0jmqMVUG_5HNy7s9HQaVFetYc130_provenance.